Obesity and COVID-19 - Obesity Research Task Force Symposium

Event Details

Since early 2020, the COVID-19 pandemic has affected almost every aspect of life for both adults and children. Obesity increases the risk of severe disease and death from COVID-19 and may interfere with immune response to vaccination. COVID-19 also may affect health behaviors and increase the risk of diabetes. This NIH Obesity Research Task Force Symposium will discuss the many ways in which COVID-19 may affect adults and children with and at risk for obesity disproportionately.

Registration Deadline

September 1, 2021

Agenda

September 3, 2021

9:00 a.m. – 9:15 a.m.

Welcoming Remarks
Diana Bianchi, M.D., Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development

9:15 a.m. – 10:00 a.m.

COVID-19 and Obesity: A Global Perspective
Barry Popkin, Ph.D., The University of North Carolina at Chapel Hill (UNC) Gillings School of Global Public Health

10:00 a.m. – 10:45 a.m.

Immune Response to Influenza Vaccination in Obesity: Implications for COVID-19
Melinda Beck, Ph.D., UNC Gillings School of Global Public Health

10:45 a.m. – 11:00 a.m.

Break

11:00 a.m. – 11:45 a.m.

SARS-CoV-2 Infection as a Potential Trigger for Diabetes: The Forest and the Trees
Dirk Homann, M.D., M.A., Icahn School of Medicine at Mount Sinai

11:45 a.m. – 12:30 p.m.

Obesity-related Behaviors in Children and Families during the COVID-19 Pandemic
Dana Dabelea, M.D., Ph.D., Colorado School of Public Health, University of Colorado, Aurora

12:30 p.m.

Adjournment